Skvamps Pharma Private Limited
About Skvamps Pharma Private Limited
Data last updated:
Skvamps Pharma Private Limited is a private limited company based in Hubli, Karnataka, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 20 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U51909KA2018PTC111429. Its GSTIN is 29ABACS0326H1ZJ (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Venkatesh Pattar Chintamani and Pradeepkumar Rajashekhar Choukimath.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hubli, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹87.26 Lakh, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹1.89 Lakh (net margin 2.2%) and EBITDA of ₹2.89 Lakh (EBITDA margin 3.3%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 18% over five years.
Company details
Contact details
Skvamps Pharma Private Limited's registered office is in Hubli, Karnataka. Its e-mail address is in the company report.
- Email
- Registered AddressM/S.Niketan Builders Private Limited H. No – 26 Priyadarshini Colony Gokul Ro, Ad, Hubli, Karnataka, India – 580030
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Skvamps Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Skvamps Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Skvamps Pharma Private Limited, buy the company report.
Financials of Skvamps Pharma Private Limited
FY 2025 filings availableSkvamps Pharma Private Limited reported revenue of ₹87.26 Lakh (up 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 11% growth in the latest year. EBITDA rose 71% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.89 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.89 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.3% | ||||
| Net Profit Margin | 2.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Skvamps Pharma Private Limited, buy the company report.
Board of directors of Skvamps Pharma Private Limited
Skvamps Pharma has 6 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkatesh Pattar Chintamani | Director | 20 Mar 2018 | 8 Years 7 Months | Current |
| Pradeepkumar Rajashekhar Choukimath | Director | 20 Mar 2018 | 8 Years 7 Months | Current |
| Suresh Sangappa Kumbar | Director | 20 Mar 2018 | 8 Years 7 Months | Current |
| Shivarudra Dharpur | Director | 20 Mar 2018 | 8 Years 7 Months | Current |
| Krishna Marigowda Lakshamma | Director | 20 Mar 2018 | 8 Years 7 Months | Current |
| Nagaraj Maruthi | Director | 20 Mar 2018 | 8 Years 7 Months | Current |
Peer comparison
Skvamps Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Krishan Lal and Company Private Limited | ₹87.49 Lakh (FY 2025) | -3.0% | New Delhi, Delhi, India | |||
| Truevalue Computers Private Limited | ₹87.44 Lakh (FY 2025) | -7.0% | Surat, Gujarat, India | |||
| Goswain Herbs Private Limited | ₹87.4 Lakh (FY 2025) | -4.0% | Kolkata, West Bengal, India | |||
| Hayan B2b Private Limited | ₹87.36 Lakh (FY 2025) | 560.0% | Adi Shankaracharaya Road, Maharashtra, India | |||
| Yatan Pharmaceuticals Private Limited | ₹87.33 Lakh (FY 2025) | 77.0% | Mumbai, Maharashtra, India | |||
| Skvamps Pharma Private Limitedthis company | ₹87.26 Lakh (FY 2025) | ₹1.89 Lakh | 2.2% | 11.0% | Hubli, Karnataka, India | |
| Excel-Global Fashion & Apparel Private Limited | ₹87.22 Lakh (FY 2025) | -54.0% | Bangalore, Karnataka, India | |||
| Stenora Pharma Private Limited | ₹87.21 Lakh (FY 2025) | 14.0% | Mumbai, Maharashtra, India | |||
| Inovex Enterprises Private Limited | ₹87.19 Lakh (FY 2025) | -1.0% | Bangalore, Karnataka, India | |||
| Solitaire Organosys Private Limited | ₹87.17 Lakh (FY 2025) | -27.0% | Burdwan, West Bengal, India | |||
| Module Pharmaceutical Private Limited | ₹87.14 Lakh (FY 2025) | 27.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Skvamps Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Skvamps Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Skvamps Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Skvamps Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29ABACS0326H1ZJ | Karnataka | Active | 22 Jun 2018 |
To see the full GST registrations and return filing status of Skvamps Pharma Private Limited, buy the company report.
Recent activity
Skvamps Pharma Private Limited has 6 board changes on record since 2018: 6 appointments. The latest: Krishna Marigowda Lakshamma was appointed as Director on 20 Mar 2018.
Frequently asked questions
Skvamps Pharma is an active private limited company based in Hubli, Karnataka, India. The company works in specialty, within the trading industry. It was incorporated on 20 March 2018 (8+ years old) and is registered under CIN U51909KA2018PTC111429.
Skvamps Pharma has 6 current directors:
- Venkatesh Pattar Chintamani - Director
- Pradeepkumar Rajashekhar Choukimath - Director
- Suresh Sangappa Kumbar - Director
- Shivarudra Dharpur - Director
- Krishna Marigowda Lakshamma - Director
- Nagaraj Maruthi - Director
The latest financial statements of Skvamps Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Skvamps Pharma is 29ABACS0326H1ZJ, registered in Karnataka.
The CIN (Corporate Identification Number) of Skvamps Pharma is U51909KA2018PTC111429. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Skvamps Pharma was incorporated on 20 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Skvamps Pharma by revenue are Krishan Lal and Company Private Limited, Truevalue Computers Private Limited, Goswain Herbs Private Limited, Hayan B2b Private Limited, Yatan Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Krishna Marigowda Lakshamma was appointed as Director on 20 Mar 2018. Nagaraj Maruthi was appointed as Director on 20 Mar 2018. Pradeepkumar Rajashekhar Choukimath was appointed as Director on 20 Mar 2018. Skvamps Pharma has 6 board changes on record in total.
The registered office of Skvamps Pharma is at MS.Niketan Builders Private Limited H. No – 26 Priyadarshini Colony Gokul Ro, Ad, Hubli, Karnataka, India – 580030.
Skvamps Pharma operates in the trading industry, in the specialty segment.
Skvamps Pharma can be reached at its registered office: MS.Niketan Builders Private Limited H. No – 26 Priyadarshini Colony Gokul Ro, Ad, Hubli, Karnataka, India – 580030.